Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.62 |
| ▸ | CTSS | P25774 | 3/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18875931 | 1.00 | CTSK (0.62) | CTSKCTSSNOD1ALDH1A1TSHR | |
| SCHEMBL14820490 | 1.00 | CTSK (0.62) | CTSKCTSSNOD1ALDH1A1TSHR | |
| SCHEMBL1926493 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7839929 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL2706071 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7555645 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7547359 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL5050858 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7555646 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7550258 | 0.98 | CTSK (0.60) | CTSKCTSSNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713321-A1 | PROTACS FOR ASK1 PROTEIN DEGRADATION: PREPARATION AND USE THEREOF | Council of Scientific and Industrial Research (IN) | 2026-03-25 | — | — | EP | disclosed |
| US-20250114350-A1 | INHIBITORS OF PRENYLTRANSFERASES AS ANTIFUNGAL AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2025-04-10 | — | — | US | disclosed |
| WO-2024236595-A1 | PROTACS FOR ASK1 PROTEIN DEGRADATION: PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2024-11-21 | — | — | WO | disclosed |
| CN-118525021-A | MALT 1-targeted proteolytic compounds | 上海齐鲁制药研究中心有限公司 | 2024-08-20 | — | — | CN | disclosed |
| EP-3040417-B1 | MACROCYCLIC PEPTIDE, METHOD FOR PRODUCING SAME, AND SCREENING METHOD USING MACROCYCLIC PEPTIDE LIBRARY | UNIV TOKYO (JP) | 2023-12-13 | — | — | EP | disclosed |
| US-11801306-B2 | Compositions and methods for targeted RNA delivery | VERVE THERAPEUTICS, INC. (US) | 2023-10-31 | — | — | US | disclosed |
| CN-112174960-B | Toll-like receptor modulating 4, 6-diamino-pyrido [3,2-D ] pyrimidine compounds | 吉利德科学公司 | 2023-10-10 | — | — | CN | disclosed |
| WO-2023061440-A1 | MODIFIED PROTEINS AND PROTEIN DEGRADERS | CULLGEN (SHANGHAI), INC. (CN) | 2023-04-20 | — | — | WO | disclosed |
| CN-112174960-A | Toll-like receptor modulating 4, 6-diamino-pyrido [3,2-D ] pyrimidine compounds | 吉利德科学公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-107108615-B | Toll-like receptor modulating 4, 6-diamino-pyrido [3,2-D ] pyrimidine compounds | 吉利德科学公司 | 2020-11-20 | — | — | CN | disclosed |
| US-20110300174-A1 | CONJUGATES FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | PFIZER VACCINES LLC (US) | 2011-12-08 | — | — | US | disclosed |
| US-8063101-B2 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | CARDAX PHARMACEUTICALS, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-20100286365-A1 | PEPTIDE-PEPTIDASE-INHIBITOR CONJUGATES AND METHODS OF MAKING AND USING SAME | AMYLIN PHARMACEUTICALS, INC. (US) | 2010-11-11 | — | — | US | disclosed |
| EP-2190845-A2 | HDAC INHIBITORS | ArQule, Inc. (US) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009026446-A9 | HDAC INHIBITORS | ARQULE, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20090124574-A1 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | CARDAX PHARMA, INC. | 2009-05-14 | — | — | US | disclosed |
| US-20090099061-A1 | SYNTHESIS OF CAROTENOID ANALOGS OR DERIVATIVES WITH IMPROVED ANTIOXIDANT CHARACTERISTICS | CARDAX PHARMACEUTICALS, INC. | 2009-04-16 | — | — | US | disclosed |
| WO-2009026446-A2 | HDAC INHIBITORS | ARQULE, INC. (US) | 2009-02-26 | — | — | WO | disclosed |
| US-4189606-A | ABOSTIFACIENT | GRUPPO LEPETIT S.P.A. (IT) | 1980-02-19 | — | — | US | disclosed |
| US-4182903-A | ABOSTIFACIENTS | GRUPPO LEPETIT S.P.A. (IT) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114350-A1 | INHIBITORS OF PRENYLTRANSFERASES AS ANTIFUNGAL AGENTS | FNTA, FNTB, FDPS | CTSK 3350/4885CTSS 2733/4885NOD1 1519/4885 |
| US-20110300174-A1 | CONJUGATES FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION | CHRNG, CHRND, CHRNA3 | CTSK 4012/4885CTSS 4095/4885NOD1 402/4885 |
| US-20090124574-A1 | Carotenoid analogs and derivatives for the prevention of platelet aggregation | PROC, PFKP, PF4 | CTSK 4132/4885CTSS 4141/4885NOD1 3064/4885 |
| US-20090099061-A1 | SYNTHESIS OF CAROTENOID ANALOGS OR DERIVATIVES WITH IMPROVED ANTIOXIDANT CHARACTERISTICS | CAT, HBZ, POLL | CTSK 2618/4885CTSS 2222/4885NOD1 2088/4885 |
| US-11801306-B2 | Compositions and methods for targeted RNA delivery | PCSK9, LDLR, PCSK7 | CTSK 453/4885CTSS 738/4885NOD1 3484/4885 |
| US-20100286365-A1 | PEPTIDE-PEPTIDASE-INHIBITOR CONJUGATES AND METHODS OF MAKING AND USING SAME | DNPEP, PEPD, VIP | CTSK 145/4885CTSS 197/4885NOD1 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.